NASDAQ:CYRX - Cryoport Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $87.14
  • Forecasted Upside: 30.92 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$66.56
▼ -2.06 (-3.00%)

This chart shows the closing price for CYRX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cryoport Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CYRX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CYRX

Analyst Price Target is $87.14
▲ +30.92% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Cryoport in the last 3 months. The average price target is $87.14, with a high forecast of $95.00 and a low forecast of $75.00. The average price target represents a 30.92% upside from the last price of $66.56.

This chart shows the closing price for CYRX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Cryoport. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/11/2021B. RileyReiterated RatingBuyMedium
11/5/2021Roth CapitalDowngradeBuy ➝ Neutral$78.00 ➝ $90.00High
11/5/2021Needham & Company LLCBoost Price TargetBuy$79.00 ➝ $93.00High
11/5/2021KeyCorpBoost Price TargetOverweight$75.00 ➝ $92.00High
10/26/2021BTIG ResearchBoost Price TargetPositive ➝ Buy$80.00 ➝ $95.00Low
10/19/2021B. RileyReiterated RatingBuyHigh
8/6/2021Roth CapitalBoost Price TargetBuy$72.00 ➝ $78.00High
8/6/2021Needham & Company LLCBoost Price TargetBuy$77.00 ➝ $79.00High
7/16/2021BTIG ResearchInitiated CoverageBuy$80.00Low
5/5/2021Needham & Company LLCBoost Price TargetBuy$73.00 ➝ $77.00High
3/15/2021UBS GroupInitiated CoverageBuy$84.00Medium
3/2/2021SVB LeerinkBoost Price TargetOutperform$50.00 ➝ $75.00High
3/2/2021Needham & Company LLCReiterated RatingBuy$73.00High
2/10/2021B. RileyBoost Price TargetBuy$69.00 ➝ $81.00Low
1/19/2021KeyCorpBoost Price TargetOverweight$54.00 ➝ $75.00Low
1/14/2021Roth CapitalBoost Price TargetBuy$60.00 ➝ $72.00High
1/12/2021B. RileyBoost Price TargetBuy$66.00 ➝ $69.00Medium
11/9/2020KeyCorpInitiated CoverageOverweight$54.00High
11/6/2020Needham & Company LLCBoost Price TargetBuy$44.00 ➝ $45.00High
9/10/2020B. RileyBoost Price Target$45.00 ➝ $66.00Medium
8/24/2020Roth CapitalBoost Price TargetBuy$42.00 ➝ $50.00High
8/24/2020Needham & Company LLCBoost Price TargetBuy$37.00 ➝ $44.00High
8/24/2020StephensBoost Price TargetOverweight$38.00 ➝ $44.00High
8/7/2020Needham & Company LLCBoost Price TargetBuy$23.00 ➝ $37.00High
7/21/2020SVB LeerinkReiterated RatingOutperformMedium
7/7/2020B. RileyBoost Price Target$24.00 ➝ $40.00Low
5/11/2020Roth CapitalBoost Price Target$25.00 ➝ $30.00Medium
5/8/2020SVB LeerinkBoost Price TargetOutperform$24.00 ➝ $25.00High
4/7/2020B. RileyReiterated RatingBuy$24.00High
3/26/2020Needham & Company LLCReiterated RatingBuy$23.00Low
3/6/2020Janney Montgomery ScottReiterated RatingBuy$25.00 ➝ $25.00Medium
3/6/2020Needham & Company LLCBoost Price TargetBuy$22.00 ➝ $23.00High
2/13/2020B. RileyLower Price TargetBuy$26.00 ➝ $24.00Medium
1/13/2020Needham & Company LLCLower Price TargetBuy$24.00 ➝ $22.00High
1/10/2020B. RileyInitiated CoverageBuy$26.00High
1/7/2020StephensInitiated CoverageOverweight$21.00High
7/19/2019B. RileySet Price TargetBuy$26.00N/A
7/15/2019SVB LeerinkReiterated RatingOutperformLow
7/1/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$22.00Medium
10/10/2018B. RileyInitiated CoverageBuy ➝ Buy$22.00Medium
8/13/2018CowenBoost Price TargetOutperform ➝ Outperform$11.00 ➝ $16.00High
7/2/2018Needham & Company LLCBoost Price TargetBuy$11.00 ➝ $19.00High
6/29/2018Roth CapitalBoost Price TargetBuy$12.50 ➝ $22.00Medium
3/8/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$10.00 ➝ $11.00Medium
11/30/2017Roth CapitalInitiated CoverageBuy ➝ Buy$12.50High
10/3/2017Janney Montgomery ScottBoost Price TargetBuy$10.00 ➝ $12.00Low
9/12/2017CowenReiterated RatingOutperform ➝ Outperform$7.50 ➝ $11.00Low
8/30/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$8.50 ➝ $10.00High
8/9/2017Janney Montgomery ScottBoost Price TargetBuy$8.00 ➝ $10.00High
8/9/2017CowenBoost Price TargetOutperform$5.50 ➝ $7.50High
7/26/2017Janney Montgomery ScottSet Price TargetBuy$8.00High
7/26/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$6.00 ➝ $8.50High
7/13/2017Needham & Company LLCReiterated RatingBuy$6.00High
7/12/2017Janney Montgomery ScottInitiated CoverageBuy ➝ Buy$8.00High
6/26/2017Needham & Company LLCReiterated RatingBuy$4.50 ➝ $6.00Low
6/16/2017CowenInitiated CoverageOutperform$5.50Low
6/16/2017CowenReiterated RatingOutperform$5.50N/A
6/1/2017Needham & Company LLCBoost Price TargetBuy$3.50 ➝ $4.50N/A
4/3/2017Needham & Company LLCInitiated CoverageBuy$3.50N/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.26 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 4 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
7/30/2021
  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 1 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/28/2021
  • 6 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
11/27/2021

Current Sentiment

  • 6 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Cryoport logo
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Read More

Today's Range

Now: $66.56
Low: $65.88
High: $69.12

50 Day Range

MA: $72.37
Low: $61.78
High: $83.29

52 Week Range

Now: $66.56
Low: $42.02
High: $86.30

Volume

181,369 shs

Average Volume

419,025 shs

Market Capitalization

$3.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Frequently Asked Questions

What sell-side analysts currently cover shares of Cryoport?

The following Wall Street sell-side analysts have issued research reports on Cryoport in the last twelve months: B. Riley, BTIG Research, KeyCorp, Needham & Company LLC, Roth Capital, SVB Leerink LLC, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for CYRX.

What is the current price target for Cryoport?

7 Wall Street analysts have set twelve-month price targets for Cryoport in the last year. Their average twelve-month price target is $87.14, suggesting a possible upside of 30.9%. BTIG Research has the highest price target set, predicting CYRX will reach $95.00 in the next twelve months. SVB Leerink LLC has the lowest price target set, forecasting a price of $75.00 for Cryoport in the next year.
View the latest price targets for CYRX.

What is the current consensus analyst rating for Cryoport?

Cryoport currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CYRX will outperform the market and that investors should add to their positions of Cryoport.
View the latest ratings for CYRX.

How do I contact Cryoport's investor relations team?

Cryoport's physical mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker's listed phone number is (949) 470-2300 and its investor relations email address is [email protected] The official website for Cryoport is www.cryoport.com.